StockData

Vivos Inc (RDGL) stock

RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30
$0.05−0.00 (-2.51%)

Close on Oct 19, 2026Market cap $23.61MP/E –Yield –

Vivos ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Vivos's ebitda for the twelve months ending Mar 31, 2018 was -$2.54M. For fiscal 2017 it was -$2.62M. The highest annual figure on record is -$1.94M in fiscal 2014.

Annual ebitda

PeriodPeriod endValueChange
FY2017Dec 31, 2017-$2.62M–
FY2016Dec 31, 2016-$4.43M–
FY2015Dec 31, 2015-$2.04M–
FY2014Dec 31, 2014-$1.94M–
FY2013Dec 31, 2013-$3.37M–
FY2012Dec 31, 2012-$5.39M–
FY2011Dec 31, 2011-$2.02M–
FY2010Dec 31, 2010-$3.18M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2018Mar 31, 2018-$286.69K–
Q4 FY2017Dec 31, 2017-$671.23K-608.3%
Q3 FY2017Sep 30, 2017-$961.80K–
Q2 FY2017Jun 30, 2017-$618.44K–
Q1 FY2017Mar 31, 2017-$363.98K–
Q4 FY2016Dec 31, 2016$132.06K–

More Vivos figures

See a number that looks wrong?